Talk Evidence - a new way of understanding antidepressant effectiveness
Medicine and Science from The BMJ
00:00
Pre Specification Matters and Would Benefit Cost Effective Analyses Also?
There is this publication bias at play. For all we know, when industry identified negative or unfavorable icers, you know, the caught on the incremental cost of ectines ratios, they just didn't publish them. And so having some type of in pre specification registration matters. This has been found true to for trials. When comparing those trials a to their to the data thay have submitted to the fda, they are much more likely to be accurate. They're muchMore likely to be registered, tan much more likelyto report the results as they were submitted to thefda. Pre-specification studies would benefit cost effective analyses also,. But i think that there's a lot of
Transcript
Play full episode
